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Introduction
• Ogilvie's syndrome, or acute colonic pseudoobstruction (ACPO), is characterized by acute
dilation of the colon, in the absence of a mechanical
lesion, which obstructs the flow of intestinal contents
• We present a case of a 51 year-old woman
presenting with symptoms of severe hypothyroidism
found to have acute colonic pseudo-obstruction

Case Presentation
History of Present Illness:
• 51 year-old woman presents with months of
progressive weakness that acutely worsened 2 days
prior to admission, is unable to get out of bed

Manifestations of Hypothyroidism
in the Gastrointestinal Tract
Esophageal Motility Disorders:
• Achalasia, esophageal spasm and
esophageal stricture
• Manifestations: dysphagia, heart burn

Dysregulation of microbiota:
• Bacterial overgrowth
• Manifestations: abdominal distention,
flatulence, bloating

Past Medical History:
• BMI of 68, obstructive sleep apnea, diastolic heart
failure, and hypothyroidism with prior medication
non-adherence
Physical Exam:
• T 37.4, HR 71, BP 119/80, RR 20, SpO2 100% (RA)
• African American woman with BMI 68, no acute
distress, cardiopulmonary exam unremarkable
• Obese abdomen, soft, non-tender, with normoactive
bowel sounds

Delayed Gastric Emptying:
• Gastroparesis
• Manifestations: dyspepsia, nausea

Diminished Colonic Motility:
• Constipation, ileus, megacolon,
pseudo-obstruction and perforation
• Manifestations: abdominal pain,
bloating, nausea/vomiting

Colonic Pseudo-Obstruction:
Before & After Neostigmine Decompression
Before

CT abdomen and pelvis with and without contrast
is obtained and reveals:
• Massive dilation of the cecum measuring up to 17
cm, transition to normal-caliber at the hepatic flexure
without evidence of obstruction or stricture

Risk Factors for ACPO
Category

Risk Factors

Surgical

Cardiac, solid organ transplant,
orthopedic/spine

Cardiac/Respiratory Shock, MI, CHF, COPD
Neurological

Dementia, Parkinson’s disease, Alzheimer’s
disease, stroke

Metabolic

Electrolyte imbalance, diabetes, renal failure,
hepatic failure

Medications

Opiates, anticholinergics, antipsychotics,
cytotoxins, clonidine

Infection

VZV, herpes, CMV

Miscellaneous

Trauma, burns, severe sepsis, idiopathic

Incidence of classic symptoms of acute colonic pseudoobstruction in a case series of 400 patients
Symptom

Incidence

Abdominal distention

100%

Abdominal pain

83%

Nausea

63%

Vomiting

57%

Constipation

51%

Diarrhea

47%

Fever

37%

Incidence of bowel tones in acute colonic pseudoobstruction
Normoactive

40%

Hypoactive

31%

Hyperactive

17%

Absent

12%

Management of ACPO
• Neostigmine can be given via bolus or infusion

Several Days Later…
Repeat laboratory data reveals:
• WBC and CMP unchanged
• Pro-calcitonin elevated to 0.35
• Repeat blood, urinalysis and urine cultures negative,
CXR without acute change, ABG normal

Acute Colonic Pseudo-Obstruction
• Case reports have demonstrated hypothyroidism as
a known risk factor for ACPO

Pathophysiology of Pseudo-Obstruction
• Hypothesized to be caused by autonomic imbalance
resulting in a hypotonic bowel
• ACPO is more common in the critically ill where
sympathetic drive is high
• Neostigmine, an acetylcholinesterase inhibitor and
parasympathomimetic, is commonly used to reverse
pseudo-obstruction
• ACPO is likely driven by sympathetic excess

After

Laboratory data:
• CBC and CMP: within normal limits
• TSH >150, FT4 <0.10
• Infectious studies including lactate, pro-calcitonin,
blood cultures, urine cultures, viral panel negative

The patient becomes more encephalopathic

Discussion

1. Before: CT revealing acute colonic pseudo-obstruction as evidenced by significant cecal dilation
up to 17 cm (noted by white arrow)
2. After: CT after decompression with neostigmine revealing resolved dilation

Acute Colonic Pseudo-Obstruction
Management Algorithm
Pseudo-Obstruction
Dilation <12 cm
Evaluate and treat reversible causes:
• Electrolytes
• Medications
• Infection
• Chronic disease management
24-48h conservative management:
NPO
NGT to suction
IVFs
Ambulation

Dilation >12 cm
Neostigmine
Equal efficacy with bolus or infusion
May repeat 1x in <72 hours

Partial or no response
Colonoscopic decompression
Partial or no response

Partial or no response
Poor surgical candidate

Surgical candidate

Percutaneous
cecostomy tube

Laparotomy with
resection

Formulation Rate
Bolus
Infusion

2mg over 15m
5mg over 12 hours (0.4mg/h)

• Neostigmine should be used with caution and often
requires ICU monitoring given risk of precipitating
bradycardia and bronchospasm
• In this case, given the patient’s operative risk
factors, chemical decompression with neostigmine
was administered and the patient improved.

Conclusions
• Hypothyroidism is a common condition with several
manifestations in the GI tract including esophageal
dysmotility, delayed gastric emptying, and
diminished colonic motility
• Pseudo-obstruction typically occurs in the critically
ill, though the underlying pathophysiology is poorly
understood, hypothyroidism can be the only predisposing factor
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